ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MLS Medical Solutn

7.72
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Medical Solutn LSE:MLS London Ordinary Share GB0009739649 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 7.72 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Result of General Meeting

10/03/2008 5:04pm

UK Regulatory


    10 March 2008

                             Source BioScience plc                             

                    ("Source BioScience" or "the Company")                     

                           RESULT OF GENERAL MEETING                           

The Company announces that at its General Meeting held today shareholders
passed unanimously the resolution for the acquisition of Autogen Bioclear UK
Limited.

                                   - ENDS -                                    

For further information, please contact:

Source BioScience plc

Nick Ash

Managing Director

Tel: 0115 973 9010

www.sourcebioscience.com

Bishopsgate Communications Ltd

Nick Rome/Gemma O'Hara

Tel: 0207 562 3350

www.bishopsgatecommunications.com

About Source BioScience:

Source BioScience plc (LSE: SBS) is a leading provider of expert, quality
services and products to the healthcare, pharma biotech and life science
research sectors. Its Healthcare operations provide screening and reference
laboratory diagnostic testing for cancer and other diseases and additional
predictive testing for treatment optimisation for clinicians and patients.
Pharma Biotech Services offers support for early stage therapeutic development,
offering a 'one-stop shop' from tissue pathology, immunohistochemistry,
sophisticated image analysis, biomarker determination and assay development to
pharmacogenomics including genotyping and gene expression analysis. The Life
Science Research services provide core laboratory research support from
conceptualization to implementation, calling upon a wide range of cutting-edge
technology platforms including an online catalogue of biomolecular tools. This
incorporates DNA sequencing, whole genome amplification and a comprehensive
library of genomic reagents and clones including cDNA and RNAi, as well as
facilitating rapid access to high quality antibodies, cell cultures, diagnostic
assays for cancer and other genetic testing, and related research tools.

The group has its headquarters in Nottingham, UK where it operates state of the
art reference laboratory facilities, with additional UK laboratory facilities
in Cambridge and Oxford. Source BioScience is CPA, GLP and GCP accredited and
is licensed by the Human Tissue Authority.



END


1 Year Medical Solutions Chart

1 Year Medical Solutions Chart

1 Month Medical Solutions Chart

1 Month Medical Solutions Chart

Your Recent History

Delayed Upgrade Clock